[1]. Buchanan JW, Anderson JH, White RI. The 1st balloon valvuloplasty: an historical note. J Vet Intern Med.2002;16(1):116–7. [2]. Cribier A, T Savin. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet.1986;1 (8472):63–7. [3]. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13(5):704–8. [4]. Figulla HR, M. Franz and A. Lauten, The history of Transcatheter Aortic Valve Implantation (TAVI)—A personal view over 25years of development. Cardiovascular Revascularization Medicine 2019;21(3):398-403 [5]. Figulla HR, Eitge N, Ferrari M. Konstruktion und in vitro Testung einer perkutan implantierbaren Aortenklappe. Z Kardiol. 1996;85(2):161. [6] Cribier A, Eltchaninoff H. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation. 2002;106(24):3006– 8. [7]. Webb JG, Chandavimol M. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113(6):842–50. [8]. Lichtenstein SV, Cheung A, Ye J. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114(6):591–6. [9]. Cribier A, Eltchaninoff H,Tron C. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43(4):698–703. [10]. Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv. 2005;66(4):465–9. [11]. Leon MB, Smith CR, Mack M, Miller C. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363:1597–1607 [12]. Leon MB, Smith CR, Mack MJ. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609–1620. [13]. Reardon MJ, Van Mieghem NM. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376:1321–1331 [14]. Smith CR, Leon MB, Mack MJ, Miller C, Moses JW, Svensson LG, et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med. 2011;364:2187–2198. [15]. Nishimura RA, Otto CM. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Vol. 135, Circulation. 2017. 1159–1195. [16]. Baumgartner H, Falk V, Bax JJ, De Bonis M. ESC Document Group; 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-91 [17]. Gurvitch R, Tay EL, Wijesinghe N. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv. 2011;78(7): 977-984. [18]. Wang H, Zhang X. Advances in the Anesthetic Management of Transcatheter Aortic Valve Implantation. Journal of Cardiothoracic and Vascular Anesthesia. 2018;32: 1464-1467. [19]. Melidi E. Cardio-anesthesiology considerations for the trans-catheter aortic valve implantation (TAVI) procedure. Hellenic Society of Cardiology. 2016:57:401-406. [20]. Webb JG, Doshi D, Mack MJ. A randomized evaluation of the SAPIEN XT transcatheter heart valve system in patients with aortic stenosis who are not candidates for surgery. JACC Cardiovasc Interv. 2015; 21:1797–806. [21]. Leon MB, Smith CR. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016; 374: 1609–20. [22]. Thourani VH, Kodali S. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: A propensity score analysis. Lancet. 2016; 387:2218–25. [23]. Erez A, Segev A, Medvedofsky D, et al. Factors affecting survival in men versus women following transcatheter aortic valve implantation. Am J Cardiol 2014; 113:701–5. [24]. Saia F, Marrozzini C, Moretti C. The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention . 2011;7:723–9. [25]. Snow TM, Ludman P, Banya W. Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: The United Kingdom TAVI Registry. Int J Cardiol . 2015;15: 253–60 [26]. Davidson L, Davidson CJ. TAVI mixed with acute kidney injury: A recipe for increased mortality. Catheter Cardiovasc Interv. 2015;85:448–9. [27]. Hamm CW, Arsalan M, Mack MJ. The future of transcatheter aortic valve implantation. Eur Heart J. 2016;37:803-810. [28]. Patel P. Anesthetic Evolution in Transcatheter Aortic Valve Replacement: Expert Perspectives From High-Volume Academic Centers in Europe and the United States. Journal of Cardiothoracic and Vascular Anesthesia. 2017: 31 : 777–790. [29]. De Backer O, Arnous S. Recovery from anemia in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation-prevalence, predictors and clinical outcome. PLoS One. 2014;9(12):1-16. [30]. Kowalski M, Deutsh C. Transcatheter aortic valve implantation at a high-volume center: the Bad Rothenfelde experience. Torakochirurgia Polska .2017; 14 (4): 215-224. [31]. Guarracino F, Baldassarri R. The anesthetic management of transcatheter aortic valve implantation. Semin Cardiothorac Vasc Anesth. 2015;9:45–8 [32]. Holmes DR Jr, Mack MJ. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200–54 [33]. Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, et al . Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study. International Journal of Cardiology. 2017: 1-3 [34]. Arai T, Lefevre T. Evaluation of the learning curve for transcatheter aortic valve implantation via the transfemoral approach. International Journal of Cardiology. 2016 ;203: 491–497. [35]. Lareyre F, Raffort J, Dommerc C, Habib Y, Bourton F,Mialhe C. A 7-Year Single-Center Experience of Transfemoral TAVI: Evolution of Surgical Activity and Impact on Vascular Outcome. Angiology.2017;69(6): 1-18. [36]. Kappetein P, Stuart J. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. The Journal of Thoracic and Cardiovascular Surgery. Clinical Guidelines. 2013; 145 (1):6-23. [37]. Moat NE, Ludman P. Long-Term Outcomes After Transcatheter Aortic Valve Implantation in High-Risk Patients With Severe Aortic Stenosis. ACC. 2011;58(20): 2130-8. [38]. Finkelstein A, Birati E. Transcatheter Aortic Valve implantation: a single-center experience of 300 cases. IMAJ .2013; 15 (10): 613–616. [39]. Caorsi C, Baeza C. Implante valvular aórtico transarterial: experiencia en Chile. Rev Med Chile. 2013; 141: 7-14. [40]. Dager A, Nuis R. Colombian Experience with Transcatheter Aortic Valve Implantation of Medtronic CoreValve. Tex Heart Inst J. 2012;39(3):351-8. [41]. Schwartz A, Goulart M. Transcatheter Aortic Valve Replacement: The Experience of One Brazilian Health Care Center. Braz J Cardiovasc Surg.2018;33(1):1-7 [42]. De Brito F, Carvalho L. Outcomes and Predictors of Mortality After Transcatheter Aortic Valve Implantation: Results of the Brazilian Registry. Catheterization and Cardiovascular Interventions. 2015;85:153-162. [43]. Nau G, Zaidel E, Echeverry D. Multicenter Experience of Transcatheter Aortic Valve Implantation Stratified by Risk in Latin American Centers. Revista Argentina de Cardiología. 2020;88:106-110. [44]. World Medical Association. Revisión Declaración de Helsinki, 59a Asamblea General, Seúl Corea Octubre 2008. [45]. Ministerio de Salud. Resolución número 8430 de 1993, (Octubre 4):1–1 [46]. Abdel-Wahab M, Landt M. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. JACC Cardiovasc Interv. 2020 May 11;13(9):1071-1082. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Anaesthesia Anaesthesia, 2022, 77 (1), pp.28-39. ⟨10.1111/anae.15563⟩ Anaesthesia, 77(1), 28-39. Wiley-Blackwell ANAESTHESIA MEDICAL JOURNAL OF AUSTRALIA r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname COVIDSurg Collaborative 2022, ' SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study ', Anaesthesia, vol. 77, no. 1, pp. 28-39 . https://doi.org/10.1111/anae.15563 Anaesthesia, 77(1), 28-39. Wiley-Blackwell Publishing Ltd Anaesthesia, vol 77, iss 1 COVIDSurg, Collaborative; GlobalSurg, Collaborative (2022). SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia, 77(1), pp. 28-39. Association of Anaesthetists 10.1111/anae.15563 Anaesthesia, 77, 1, pp. 28-39 Anaesthesia, 77, 28-39